SIC 2835 – In Vitro and In Vivo Diagnostic Substances
| Valuation | |
|---|---|
| Market Cap ($M) | 35.86 |
| Enterprise Value ($M) | 32.50 |
| Book Value ($M) | 9.71 |
| Book Value / Share | 0.58 |
| Price / Book | 3.69 |
| NCAV ($M) | -55.71 |
| NCAV / Share | -3.31 |
| Price / NCAV | -0.64 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -3.15 |
| Return on Assets (ROA) | -0.58 |
| Return on Equity (ROE) | -1.69 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 0.50 |
| Current Ratio | 0.53 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 4.79 |
| Assets | 70.22 |
| Liabilities | 60.51 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Smith Patrick W | |||
| 13G | Pura Vida Investments, Llc | 4.57 | -12.93 | |
| 13G/A | Bio-rad Laboratories, Inc. | 8.97 | 25.90 | |
| 13D/A | Broadwood Partners, L.p. | 37.60 | -91.11 | |
| 13G/A | AWM Investment Company, Inc. | 9.10 | -89.60 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 23,483 | 37,739 | 62.22 | |
| 18,321 | 50,722 | 36.12 | |
| 61,204 | 366,707 | 16.69 | |
| 1,962 | 6,096 | 32.19 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| NVCT – Nuvectis Pharma, Inc. | OCEA – Ocean Biomedical, Inc. |
| OCGN – Ocugen, Inc. | OKYO – OKYO Pharma Limited |
| ONCO – Onconetix, Inc. |
Financial data and stock pages provided by
Fintel.io